A detailed history of Creative Planning transactions in Cerus Corp stock. As of the latest transaction made, Creative Planning holds 24,809 shares of CERS stock, worth $42,671. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,809
Previous 16,398 51.29%
Holding current value
$42,671
Previous $28,000 53.57%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$1.7 - $2.39 $14,298 - $20,102
8,411 Added 51.29%
24,809 $43,000
Q2 2024

Aug 15, 2024

SELL
$1.62 - $2.04 $43 - $55
-27 Reduced 0.16%
16,398 $28,000
Q1 2024

May 10, 2024

BUY
$1.66 - $2.42 $27,265 - $39,748
16,425 New
16,425 $31,000
Q2 2023

Jul 21, 2023

BUY
$1.79 - $2.9 $18,583 - $30,107
10,382 New
10,382 $25,000
Q4 2017

Jan 17, 2018

SELL
$2.76 - $3.95 $27,933 - $39,977
-10,121 Closed
0 $0
Q3 2017

Oct 17, 2017

BUY
$2.22 - $2.73 $22,468 - $27,630
10,121
10,121 $28,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $305M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.